Franklin Biotechnology Disc A Acc $

Performance History30/06/2014
Growth of 1,000 (EUR)
Franklin Biotechnology Disc A Acc $
Fund25.813.324.957.211.4
+/-Cat8.211.40.26.0-1.8
+/-Idx15.8-5.6-16.9-3.32.3
 
Key Stats
NAV
29/07/2014
 USD 25.90
Day Change 2.06%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394709
Fund Size (Mil)
30/06/2014
 USD 3196.76
Share Class Size (Mil)
30/06/2014
 USD 2698.90
Max Initial Charge 5.75%
Total Expense Ratio
30/04/2014
  1.82%
Investment Objective: Franklin Biotechnology Disc A Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns29/07/2014
YTD14.16
3 Years Annualised34.68
5 Years Annualised25.54
10 Years Annualised12.53
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Jerel Banks
01/09/2012
Inception Date
03/04/2000
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Disc A Acc $30/04/2014
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks95.590.0095.59
Bonds0.000.000.00
Cash4.410.004.41
Other0.000.000.00
Top 5 Regions%
United States95.29
United Kingdom3.04
Canada1.02
Eurozone0.65
Japan0.00
Top 5 Sectors%
No Data Available
Top 5 HoldingsSector%
Gilead Sciences IncHealthcareHealthcare10.93
Biogen Idec IncHealthcareHealthcare7.62
Amgen IncHealthcareHealthcare5.19
Celgene CorpHealthcareHealthcare5.05
Regeneron Pharmaceuticals IncHealthcareHealthcare5.00
Franklin Biotechnology Disc A Acc $